When will Adalimumab-adaz Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Adalimumab-adaz Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Adalimumab-adaz Injection

Brand names: Hyrimoz

Category: Rheumatology

Not specified 5

FDA status: To Be Discontinued · Last FDA update: Jan 13, 2026 · First posted: Jan 13, 2026 · 1 manufacturers, 5 listed presentations

As of Jan 13, 2026, the FDA lists Adalimumab-adaz Injection as being discontinued. Of 5 manufacturer presentations, 5 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Adalimumab-adaz Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64) NDC 61314-473-64	Sandoz Inc.	Not specified	Equivalent Sandoz format is available.
Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68) NDC 61314-454-68	Sandoz Inc.	Not specified	Equivalent Sandoz format is available.
Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36) NDC 61314-454-36	Sandoz Inc.	Not specified	Equivalent Sandoz format is available.
Hyrimoz, Injection, Kit (NDC 61314-517-36) NDC 61314-517-36	Sandoz Inc.	Not specified	Equivalent Sandoz format is available.
Hyrimoz, Injection, Kit (NDC 61314-531-64) NDC 61314-531-64	Sandoz Inc.	Not specified	Equivalent Sandoz format is available.

Related medications in shortage

Other Rheumatology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Adalimumab-adaz Injection (FDA data as of Jan 13, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Adalimumab-adaz Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Adalimumab-adaz Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/adalimumab-adaz-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).